Rapid Testing for Multiple Pathogens Gives Canadian Laboratories a Fast and Effective Tool to Respond to Symptomatic Patients for Either Isolated Cases or Epidemic Outbreaks ROCKVILLE, MD and SEOUL, SOUTH KOREA–Seegene, Inc., a leader in multiplex PCR pathogen diagnostic testing, today announced that it has received a Medical Device License from Health Canada for its […]
SHANGHAI /PRNewswire-Asia/ — WuXi AppTec Inc. today announced that it has entered into a partnership with QIAGEN to provide an integrated single solution for molecular biomarker development, validation and personalized healthcare targets to their respective client bases. QIAGEN will provide a complete portfolio of instrumentation, training, and consumables and WuXi AppTec will provide laboratory facilities […]
Litigation with HandyLab Settled HOPKINTON, Mass — Caliper Life Sciences, Inc. (NASDAQ: CALP), a leading provider of life sciences tools, announced today that Becton, Dickinson and Company (BD), has acquired a license to Caliper’s microfluidics patent portfolio. “We are pleased that Becton Dickinson is leveraging the strength of our microfluidics intellectual property to facilitate the […]
Major News Media Missed the Mark – Noninvasive Test Will Provide Hope for 90% of Women Diagnosed With This Silent Killer SUNNYVALE, CA–On December 9th, 2009, Arrayit Corporation (OTC.BB:ARYC – News), a leading manufacturer of products and services for disease prevention, treatment and cure, announced a breakthrough in ovarian cancer screening utilizing a microarray-based diagnostic […]
HERCULES, CA–Bio-Rad Laboratories, Inc. (NYSE:BIO – News) and (NYSE:BIO.B – News), a multinational manufacturer and distributor of life science research and clinical diagnostics products, announced today that it has completed the purchase of certain diagnostics businesses of Biotest AG, including its diagnostics products in the areas of blood transfusion testing, transplantation, and infectious diseases for […]
VANCOUVER–Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) announced today that the Company has received a Notice of Allowance from the European Patent Office for the patent entitled “Sensitive Immunochromatographic Assay”, referred to as the “Fong Patent”. This critical patent protects key aspects of Response Biomedical’s lateral flow immunoassays conducted with the proprietary RAMP® testing platform. […]
First Rapid and Accurate Surveillance Test for vanA the Resistance Gene Most Associated with Hospital-Acquired VRE Infections – 45-Minute Test Further Expands Industry Leading Molecular HAI Test Portfolio SUNNYVALE, Calif. — Cepheid (Nasdaq: CPHD) today announced it has received clearance from the U.S. Food & Drug Administration (FDA) to market Xpert® vanA, the first rapid […]
HERCULES, CA and DUNDEE, SCOTLAND — Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B), a multinational manufacturer and distributor of life science research and clinical diagnostics products, and Axis-Shield plc (LSE: ASD) (OSE: ASD), an international in-vitro diagnostics (IVD) company, today announced the launch of Bio-Rad’s BioPlex(R) 2200 Anti-CCP test for the early detection of […]
Xpert(R) Flu A Panel Identifies the 2009 H1N1 Influenza Virus in Less Than One Hour SUNNYVALE — Cepheid (Nasdaq: CPHD) today announced it has been granted Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its Xpert® Flu A Panel test. The test, which runs on Cepheid’s GeneXpert® System, identifies the […]
FDA Authorizes Emergency Use of Assay for the Detection and Differentiation of the 2009 H1N1 Influenza A Virus SANTA CLARA, Calif. & POTOMAC FALLS, Va.–TessArae, LLC, a privately held company, and Affymetrix Inc., (NASDAQ:AFFX) today announced that the Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) to TessArae for its TessArray® Resequencing […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
